1. Home
  2. AVTX vs RGCO Comparison

AVTX vs RGCO Comparison

Compare AVTX & RGCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • RGCO
  • Stock Information
  • Founded
  • AVTX 2011
  • RGCO 1912
  • Country
  • AVTX United States
  • RGCO United States
  • Employees
  • AVTX N/A
  • RGCO N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • RGCO Oil & Gas Production
  • Sector
  • AVTX Health Care
  • RGCO Utilities
  • Exchange
  • AVTX Nasdaq
  • RGCO Nasdaq
  • Market Cap
  • AVTX 248.3M
  • RGCO 219.2M
  • IPO Year
  • AVTX 2015
  • RGCO N/A
  • Fundamental
  • Price
  • AVTX $15.14
  • RGCO $21.87
  • Analyst Decision
  • AVTX Strong Buy
  • RGCO
  • Analyst Count
  • AVTX 9
  • RGCO 0
  • Target Price
  • AVTX $30.14
  • RGCO N/A
  • AVG Volume (30 Days)
  • AVTX 412.1K
  • RGCO 9.3K
  • Earning Date
  • AVTX 11-06-2025
  • RGCO 11-18-2025
  • Dividend Yield
  • AVTX N/A
  • RGCO 3.87%
  • EPS Growth
  • AVTX N/A
  • RGCO 5.90
  • EPS
  • AVTX N/A
  • RGCO 1.32
  • Revenue
  • AVTX $192,000.00
  • RGCO $94,120,500.00
  • Revenue This Year
  • AVTX N/A
  • RGCO $19.22
  • Revenue Next Year
  • AVTX N/A
  • RGCO $2.97
  • P/E Ratio
  • AVTX N/A
  • RGCO $16.17
  • Revenue Growth
  • AVTX N/A
  • RGCO 12.04
  • 52 Week Low
  • AVTX $3.39
  • RGCO $19.06
  • 52 Week High
  • AVTX $19.41
  • RGCO $23.82
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 48.12
  • RGCO 48.82
  • Support Level
  • AVTX $14.16
  • RGCO $21.00
  • Resistance Level
  • AVTX $16.03
  • RGCO $22.00
  • Average True Range (ATR)
  • AVTX 1.27
  • RGCO 0.41
  • MACD
  • AVTX -0.42
  • RGCO 0.09
  • Stochastic Oscillator
  • AVTX 23.40
  • RGCO 43.26

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About RGCO RGC Resources Inc.

RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.

Share on Social Networks: